Latest Press Releases

Allogene Therapeutics Announces Webinar to Review Initial ALLO-501 Phase 1 Data on May 29, 2020

May 26 2020

American Society of Clinical Oncology (ASCO) Abstract Reports Initial ALLO-501 ALPHA Phase 1 Data in Relapsed/Refractory Non-Hodgkin Lymphoma

May 13 2020

Allogene Therapeutics Reports First Quarter 2020 Financial Results

May 06 2020